Literature DB >> 15710811

Histopathologic features of conjunctival filtering blebs.

Brian A Francis1, Lee T Du, Kathryn Najafi, Raghu Murthy, Usha Kurumety, Narsing Rao, Don S Minckler.   

Abstract

OBJECTIVES: To characterize and compare the histological features of conjunctiva obtained during the repair of trabeculectomy and inadvertent blebs and to assess the effects of antifibrotic agents.
METHODS: We used routine paraffin processing and light microscopy to examine conjunctival specimens from 28 eyes undergoing late bleb revision: 19 leaking trabeculectomy blebs, 5 nonleaking trabeculectomy blebs, and 4 inadvertent blebs. Quantitative analysis of histological characteristics included conjunctival epithelial thickness, stromal vascularity, squamous metaplasia, stromal inflammatory cell infiltrate, and goblet cell density. The type of surgery, presence of leaks, prior topical medication, and antifibrotic use were correlated with histological findings.
RESULTS: Trabeculectomy blebs (leaking and nonleaking) showed decreases in overall epithelial thickness (P<.02), goblet cell density (P<.001), and vascularity (P<.001) compared with inadvertent bleb controls. Conjunctiva exposed to antifibrotics had fewer layers of epithelial cells than those with no prior exposure (P<.05).
CONCLUSIONS: Histological analysis of thin blebs excised following trabeculectomy demonstrated decreases in epithelial thickness and goblet cell density compared with inadvertent blebs. Both leaking and nonleaking trabeculectomy blebs exhibited decreases in localized stromal vascularity and increases in surrounding stromal vascularity compared with normal conjunctiva.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710811     DOI: 10.1001/archopht.123.2.166

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

1.  Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model.

Authors:  Zachary L Lukowski; Jeff Min; Ashley R Beattie; Craig A Meyers; Monica A Levine; Glenn Stoller; Gregory S Schultz; Don A Samuelson; Mark B Sherwood
Journal:  J Glaucoma       Date:  2013-02       Impact factor: 2.503

2.  Validation of the glaucoma filtration surgical mouse model for antifibrotic drug evaluation.

Authors:  Li-Fong Seet; Wing Sum Lee; Roseline Su; Sharon N Finger; Jonathan G Crowston; Tina T Wong
Journal:  Mol Med       Date:  2011-01-11       Impact factor: 6.354

3.  Aberrant wound-healing response in mitomycin C-treated leaking blebs: a histopathologic study.

Authors:  Victor M Elner; Paula Anne Newman-Casey; A Jayaprakash Patil; Andrew Flint; Jyotirmay Biswas; Sayoko E Moroi; Vaijayanthi Pushparaj; Deepak P Edward
Journal:  Arch Ophthalmol       Date:  2009-08

4.  Update on amniotic membrane transplantation.

Authors:  Jingbo Liu; Hosam Sheha; Yao Fu; Lingyi Liang; Scheffer Cg Tseng
Journal:  Expert Rev Ophthalmol       Date:  2010-10

Review 5.  Mitomycin: clinical applications in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model.

Authors:  Jeff Min; Zachary L Lukowski; Monica A Levine; Craig A Meyers; Ashley R Beattie; Gregory S Schultz; Don A Samuelson; Mark B Sherwood
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

Review 7.  Bulbar Conjunctival and Tenon's Layer Thickness Measurement using Optical Coherence Tomography.

Authors:  J Howlett; K Vahdani; J Rossiter
Journal:  J Curr Glaucoma Pract       Date:  2014-06-12

8.  Modulating Ocular Scarring in Glaucoma Filtration Surgery Using the Epigenetic Adjunct Suberoylanilide Hydroxamic Acid.

Authors:  Cooper D Rodgers; Zachary L Lukowski; Jeff Min; Gina M Martorana; Mary-Kate Wilson; Jamie L Schaefer; Monica A Levine; Craig A Meyers; C Richard Blake; Gregory S Schultz; Mark B Sherwood
Journal:  J Curr Glaucoma Pract       Date:  2019 Jan-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.